S. van der Flier

Center For Policy Research — United States

Agricultural and Biological Sciences · Life Sciences

14h-index1.3kcitations26works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chromosomal and Genetic Variations(5), Health Systems, Economic Evaluations, Quality of Life(5), Genomic variations and chromosomal abnormalities(5), Advanced biosensing and bioanalysis techniques(4), Genomics and Chromatin Dynamics(3)

Publications26 total

Continuous monitoring of the use of molecular diagnostics in oncology: advancing towards a learning health system
2025Open Access
New opportunities for accessing promising non-oncological orphan drugs
The Lancet Regional Health - Europe·2025· 1 citedOpen Access
Controlled medication available with Orphan Drug Access Protocol. Promising non-oncological orphan drugs reach patients faster
Pure Amsterdam UMC·2024
1723P Improving access to molecular tumour boards for complex genomic profiles: A healthcare policy from the Netherlands
Annals of Oncology·2023Open Access
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis
Journal of Medical Internet Research·2022· 2 citedOpen Access
Novel ways to fund cost-efficiency studies of expensive drugs: Efforts to maintain sustainable healthcare expenditure in the Netherlands.
Journal of Clinical Oncology·2022· 4 cited
Response to: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?
The Breast·2022· 1 citedOpen Access
Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer
The Breast·2021· 40 citedOpen Access
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis (Preprint)
2021
Immunohistochemical Study of the BCAR1/p130Cas Protein in Non-Malignant and Malignant Human Breast Tissue
The International Journal of Biological Markers·2001· 17 citedOpen Access
Tamoxifen Resistance in Breast Cancer
Drugs·2001· 103 cited
BCAR1and Anti-estrogen Resistance of Human Breast Cancer
Data Archiving and Networked Services (DANS)·2000Open Access
Bcar1/p130Cas Protein and Primary Breast Cancer: Prognosis and Response to Tamoxifen Treatment
JNCI Journal of the National Cancer Institute·2000· 118 citedOpen Access
BCAR1, a Human Homologue of the Adapter Protein p130Cas, and Antiestrogen Resistance in Breast Cancer Cells
JNCI Journal of the National Cancer Institute·2000· 145 cited
BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas
International Journal of Cancer·2000· 43 cited
Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.
PubMed·1996· 168 cited
Analysis of N-ras Mutations in Human Cutaneous Melanoma: Tumor Heterogeneity Detected by Polymerase Chain Reaction/Single-Stranded Conformation Polymorphism Analysis
Recent results in cancer research/Recent Results in Cancer Research·1995· 49 cited
Analysis of N-ras mutations in human cutaneous melanoma: tumor heterogeneity detected by polymerase chain reaction/single-stranded conformation polymorphism analysis
Cancer Research·1995· 1 cited
Fluorescence ratio measurements of double‐labeled probes for multiple in situ hybridization by digital imaging microscopy
Cytometry·1992· 88 citedOpen Access
Quantification of fluorescence in situ hybridization signals by image cytometry
Cytometry·1992· 42 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Petra M. Nederlof(8), Anton K. Raap(6), Hans J. Tanke(6), Arend Brinkman(5), Lambert C. J. Dorssers(5), Rawa K. Ismail(4), Jesper van Breeschoten(4), Michel W.J.M. Wouters(4), Maaike van Dartel(4), Anna M.G. Pasmooij(4), Doranne L. Hilarius(4), M. van der Ploeg(3), Andrea van Elsas(3), Shuraila F. Zerp(3), D. J. Ruiter(3), Peter I. Schrier(3), John A. Foekens(3), Anthonius de Boer(3), Elisabeth M. Kok(2), Frank H.A.C. Kornips(2)